Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• Adverse perinatal outcomes associated with different classes of antiretroviral drugs in pregnant women with HIV1 passage
• Comparative efficacy and safety and dolutegravir and lamivudine in treatment naive HIV patients1 passage
• Continuous isoniazid for the treatment of latent tuberculosis infection in people living with HIV1 passage
• Efficacy and safety of doravirine/islatravir in heavily treatment-experienced participants living with HIV-1: results from a randomized trial1 passage
• Efficacy, safety, and pharmacokinetics of lenacapavir oral bridging when subcutaneous lenacapavir cannot be administered1 passage
• Exploring the PREVENT HF score and myocardial function among persons with HIV1 passage
• Greater remnant lipoprotein cholesterol reduction with pitavastatin compared with pravastatin in HIV-infected patients1 passage
• HIV-1 pretreatment drug resistance negatively impacts outcomes of first-line antiretroviral treatment1 passage
• HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer1 passage
• Perinatal outcomes among pregnant women with HIV initiating antiretroviral therapy preconception and antenatally1 passage
• Randomized clinical trial on efficacy of fixed-dose efavirenz/tenofovir/emtricitabine on alternate days versus continuous treatment1 passage
• Real-world clinical and economic outcomes from rapid start antiretroviral therapy in HIV: systematic review and meta-analysis1 passage
• The association between HIV, antiretroviral therapy, and gestational diabetes mellitus1 passage
• The immunogenicity of an HIV-1 Gag conserved element DNA vaccine in people with HIV and receiving antiretroviral therapy1 passage
• Willingness to switch to long-acting regimens among people with HIV: a systematic review and meta-analysis1 passage